U.S. markets open in 6 hours 22 minutes
  • S&P Futures

    3,426.50
    -25.25 (-0.73%)
     
  • Dow Futures

    27,984.00
    -205.00 (-0.73%)
     
  • Nasdaq Futures

    11,600.25
    -63.25 (-0.54%)
     
  • Russell 2000 Futures

    1,618.30
    -17.30 (-1.06%)
     
  • Crude Oil

    38.89
    -0.96 (-2.41%)
     
  • Gold

    1,899.30
    -5.90 (-0.31%)
     
  • Silver

    24.27
    -0.40 (-1.64%)
     
  • EUR/USD

    1.1833
    -0.0035 (-0.30%)
     
  • 10-Yr Bond

    0.8410
    0.0000 (0.00%)
     
  • Vix

    27.55
    -0.56 (-1.99%)
     
  • GBP/USD

    1.3005
    -0.0034 (-0.26%)
     
  • USD/JPY

    104.9550
    +0.2650 (+0.25%)
     
  • BTC-USD

    13,075.46
    -1.56 (-0.01%)
     
  • CMC Crypto 200

    262.69
    +1.24 (+0.47%)
     
  • FTSE 100

    5,860.28
    +74.63 (+1.29%)
     
  • Nikkei 225

    23,494.34
    -22.25 (-0.09%)
     

CLASS ACTION UPDATE for GWRE, STAA and VXRT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

·4 mins read

NEW YORK, NY / ACCESSWIRE / September 15, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

GWRE Shareholders Click Here: https://www.zlk.com/pslra-1/guidewire-software-inc-loss-submission-form?prid=9288&wire=1
STAA Shareholders Click Here: https://www.zlk.com/pslra-1/staar-surgical-company-information-request-form?prid=9288&wire=1
VXRT Shareholders Click Here: https://www.zlk.com/pslra-1/vaxart-inc-information-request-form-2?prid=9288&wire=1

* ADDITIONAL INFORMATION BELOW *

Guidewire Software, Inc. (NYSE:GWRE)

GWRE Lawsuit on behalf of: investors who purchased March 6, 2019 - March 4, 2020
Lead Plaintiff Deadline : September 23, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/guidewire-software-inc-loss-submission-form?prid=9288&wire=1

According to the filed complaint, during the class period, Guidewire Software, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) that the Company's transition to the cloud was not going well; (2) that Guidewire's cloud-based products needed to be improved to meet customer needs and catch up with rival systems; (3) that the Company's failed transition to the cloud was also hurting Guidewire's traditional on-premise business; and (4) as a result, Guidewire's revenue guidance, including guidance principally based on significantly increasing demand for the Company's cloud-based products, was baseless and unattainable.

Staar Surgical Company (NASDAQ:STAA)

STAA Lawsuit on behalf of: investors who purchased February 26, 2020 - August 10, 2020
Lead Plaintiff Deadline : October 19, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/staar-surgical-company-information-request-form?prid=9288&wire=1

According to the filed complaint, during the class period, Staar Surgical Company made materially false and/or misleading statements and/or failed to disclose that: the Company was overstating and/or mischaracterizing: (1) its sales and growth in China; (2) its marketing spend; (3) its research and development expenses; and that as a result of the foregoing, (4) Defendants' public statements were materially false and misleading at all relevant times.

Vaxart, Inc. (NASDAQ:VXRT)

VXRT Lawsuit on behalf of: investors who purchased June 25, 2020 - July 25, 2020
Lead Plaintiff Deadline : October 23, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/vaxart-inc-information-request-form-2?prid=9288&wire=1

According to the filed complaint, during the class period, Vaxart, Inc. made materially false and/or misleading statements and/or failed to disclose that: 1) Vaxart exaggerated the prospects of its COVID-19 vaccine candidate, including its purported role or involvement in Operation Warp Speed ('OWS'), a program which commits the federal government to massive funding for the development of COVID-19 vaccines; 2) Vaxart's COVID-19 vaccine candidate had no reasonable prospect for mass production and marketing and was not among the companies chosen to receive significant financial support from OWS to produce hundreds of millions of vaccine doses; and 3) Vaxart's COVID-19 vaccine candidate was merely selected to participate in preliminary U.S. government studies to determine potential areas for possible OWS partnership and support.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP



View source version on accesswire.com:
https://www.accesswire.com/606176/CLASS-ACTION-UPDATE-for-GWRE-STAA-and-VXRT-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders